Gastroesophageal reflux disease: a review

J Maret-Ouda, SR Markar, J Lagergren - Jama, 2020 - jamanetwork.com
Importance Gastroesophageal reflux disease (GERD) is defined by recurrent and
troublesome heartburn and regurgitation or GERD-specific complications and affects …

Proton pump inhibitor use: systematic review of global trends and practices

LGT Shanika, A Reynolds, S Pattison… - European Journal of …, 2023 - Springer
Abstract Purpose Proton pump inhibitors (PPIs) reduce acid secretion in the stomach and
rank as one of the most widely used acid-suppressing medicines globally. While PPIs are …

Use of proton pump inhibitors in adults in France: a nationwide drug utilization study

M Lassalle, T Le Tri, M Bardou, M Biour… - European journal of …, 2020 - Springer
Purpose Proton pump inhibitor (PPI) drugs are approved for the management of gastric acid–
related diseases, mainly treatment of gastroesophageal reflux disease, treatment of …

Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015

F Torres-Bondia, J de Batlle, L Galván, M Buti… - BMC Public Health, 2022 - Springer
Abstract Background Proton pump inhibitors (PPIs) are one of the most commonly
prescribed pharmacological groups. Their high prevalence and duration of use are of …

Problems associated with deprescribing of proton pump inhibitors

H Helgadottir, ES Bjornsson - International journal of molecular sciences, 2019 - mdpi.com
Proton pump inhibitors (PPIs) are recommended as a first-line treatment for
gastroesophageal reflux disease (GERD) and other acid related disorders. In recent years …

The use and misuse of proton pump inhibitors: an opportunity for deprescribing

TS Dharmarajan - Journal of the American Medical Directors Association, 2021 - Elsevier
Proton pump inhibitors (PPIs) are proven medications of choice for gastroesophageal reflux
disease (GERD), acid-related disorders, erosive esophagitis, Barrett esophagus, prevention …

Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis

L Muheim, A Signorell, S Markun… - Therapeutic …, 2021 - journals.sagepub.com
Background: Proton-pump inhibitors (PPI) are among the most prescribed drugs worldwide,
and a large body of evidence raises concerns about their inappropriate use. Previous …

Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study

J Maret-Ouda, J Panula, G Santoni, S **e… - Journal of …, 2023 - Springer
Background Recent research indicates that use of proton pump inhibitors (PPIs) is
associated with pneumonia, but existing evidence is inconclusive because of …

Systematic review with meta‐analysis: the risks of proton pump inhibitors during pregnancy

CM Li, A Zhernakova, L Engstrand… - Alimentary …, 2020 - Wiley Online Library
Background There have been safety concerns considering long‐term proton pump inhibitor
(PPI) use, also during pregnancy. Aims To assess the risk of adverse neonatal outcomes …

Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016

B Daniels, SA Pearson, NA Buckley… - Therapeutic …, 2020 - journals.sagepub.com
Background: Proton-pump inhibitors (PPIs) are among the most prescribed medicines
worldwide and concern about their long-term use is growing. We used dispensing claims for …